SciVision Biotech Balance Sheet Health
Financial Health criteria checks 6/6
SciVision Biotech has a total shareholder equity of NT$1.6B and total debt of NT$323.8M, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are NT$2.2B and NT$533.7M respectively. SciVision Biotech's EBIT is NT$199.6M making its interest coverage ratio -29.9. It has cash and short-term investments of NT$745.0M.
Key information
19.9%
Debt to equity ratio
NT$323.84m
Debt
| Interest coverage ratio | -29.9x |
| Cash | NT$745.00m |
| Equity | NT$1.63b |
| Total liabilities | NT$533.67m |
| Total assets | NT$2.16b |
Recent financial health updates
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly
Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly
Jan 18Recent updates
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio
Apr 01Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly
Apr 20SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital
Apr 02Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?
Mar 15Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend
Feb 25Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?
Feb 05Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly
Jan 18Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?
Jan 01
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years
Dec 14Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend
Nov 25Financial Position Analysis
Short Term Liabilities: 1786's short term assets (NT$1.0B) exceed its short term liabilities (NT$145.0M).
Long Term Liabilities: 1786's short term assets (NT$1.0B) exceed its long term liabilities (NT$388.7M).
Debt to Equity History and Analysis
Debt Level: 1786 has more cash than its total debt.
Reducing Debt: 1786's debt to equity ratio has reduced from 40.3% to 19.9% over the past 5 years.
Debt Coverage: 1786's debt is well covered by operating cash flow (84%).
Interest Coverage: 1786 earns more interest than it pays, so coverage of interest payments is not a concern.